<code id='25D825CB24'></code><style id='25D825CB24'></style>
    • <acronym id='25D825CB24'></acronym>
      <center id='25D825CB24'><center id='25D825CB24'><tfoot id='25D825CB24'></tfoot></center><abbr id='25D825CB24'><dir id='25D825CB24'><tfoot id='25D825CB24'></tfoot><noframes id='25D825CB24'>

    • <optgroup id='25D825CB24'><strike id='25D825CB24'><sup id='25D825CB24'></sup></strike><code id='25D825CB24'></code></optgroup>
        1. <b id='25D825CB24'><label id='25D825CB24'><select id='25D825CB24'><dt id='25D825CB24'><span id='25D825CB24'></span></dt></select></label></b><u id='25D825CB24'></u>
          <i id='25D825CB24'><strike id='25D825CB24'><tt id='25D825CB24'><pre id='25D825CB24'></pre></tt></strike></i>

          fashion

          fashion

          author:hotspot    Page View:67581
          Andrew Trister, an oncologist and veteran of big technology companies and research, is Verily's new chief scientific officer.

          As Verily aims to get on track, the Alphabet life science company has hired Andrew Trister, an oncologist and veteran of big technology companies and research, as its new chief scientific officer.

          Trister will lead Verily’s population health initiatives, including public health solutions like the company’s ongoing work to combat disease-carrying mosquito populations and a program that helps wastewater treatment plants monitor for pathogens. He will also consult across Verily’s diverse projects.

          advertisement

          Trister’s focus on public health will build on his recent role as a deputy director at the Bill and Melinda Gates Foundation, where he led digital health, including a project to build tech infrastructure to help with malaria testing. Trister also led the foundation’s Covid-19 response. In 2016, he was an early health hire at Apple. There, he worked on programs like a heart health study with Janssen, an app to promote healthy habits with Aetna, and research into digital biomarkers for Alzheimer’s disease with Eli Lilly and Evidation.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Why Novartis is going to walk from its acquisition of MorphoSys
          Why Novartis is going to walk from its acquisition of MorphoSys

          MollyFerguson/STATNovartissaidMondaythatitintendstobuyMorphoSysforjustunder$3billion.Thedealwillnotc

          read more
          In Memoriam: Notable people who died in 2023
          In Memoriam: Notable people who died in 2023

          1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

          read more

          STAT Executive Editor Rick Berke on STAT's 8th birthday

          PhotosfromSTAT'sfirstyearofpublishinglaidoutforanedit.AlissaAmbrose/STATTodaySTATturns8.Intheseannua